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Summary
The activation of blood coagulation factor X by factor IXa is
strongly stimulated by the non-enzymatic cofactors phospholipid,
Ca" and activated factor VIII. In this paper we present a method
by which we were able to determine binding affinities of
factor IXa for phospholipids (either in the absence or presence of
factor VIIIa) from kinetic measurements of factor X activation. It
is shown that rates of factor X activation in the presence of
phospholipids can be saturated with an excess factor VIIIa at
limiting amounts of factor IXa and vice versa. Our data indicate
that the enzymatic unit in the intrinsic factor X activator is a l: l
stoichiometrical complex of factor IXa and factor VIIIa bound to
phospholipid. Titrations with factor IXa at fixed concentrations
of phospholipid and factor X show that the apparent dissociation
constant of factor IXa for phospholipid is lowered from 10-6 M to
10-8 M by the presence of facto. Vttt". W" conclude, that in
analogy with the role of factor Va in prothrombin activation,
phospholipid-bound factor VIIIa tunctions as a high-affinity bind-
ing site ('receptor") for factor IXa in the intrinsic factor X
activating complex. Therefore, factor WIIa increases the
observed Vmax of factor X activation by 1) enhancing the ko, of
the reaction and 2) increasing the amount of phospholipid-bound
factor IXa that participates in factor X activation.
Introduc{ion
In the intrinsic pathway of the blood coagulation cascade the
rymogen factor X is converted into factor Xa by the serine
protease factor IXa (For a review see ref.l). The rate of
factor Xa formation is strongly increased Uy itre presence of
negatively charged phospholipids, Ca2+ ions and activated factor
VIII (For a review on factor VIII see ref.2). It is thought that
during factor X activation, factor IXa and VIIIa are associated in
a complex adsorbed at the phospholipid surface. This complex is
called the intrinsic factor X activator or the intrinsic factor X
activating complex (3-7). A detailed understanding of the mode
of action of the intrinsic factor X activator ultimately requires
quantification of the interactions between the individual com-
ponents. Binding parameters, i. e. dissociation constants and
number of binding sites, have been determined for interaction of
factors IXa and X with phospholipid vesicles of varying composi-
tion (8, 9). Until now no data are available, however, on
interactions that involve factor VIII.
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The organisation of the components of the factor X activating
complex as postulated above strongly resembles the structure of
the prothrombinase complex (3-10). Data on the interactions
between the components of the latter complex have been
obtained by several methods. One technique was to infer binding
parameters from the kinetics of prothrombin activation (ll, 12).
The binding data presented in this paper, which were derived
from kinetic studies of factor X activation, provide evidence that
a factor IXa-factor Vllla-phospholipid complex is the catalyric
unit in factor X activation and further indicate that the incorpora-
tion of factor IXa in this enzyme complex is strongly promoted by
activated factor VIII.
Materials and Mcthods
Materials
52337 (Bz-Ile-Glu[Piperidyl]-Gly-Arg-pnitroanilide) was purchased
from Kabi AB, Sweden; Sephacryl-S300 was from Pharmacia Sweden.
Phosphatidylcholine (18 : l-l18 : 1";-phosphatidylcholine) was from Sigma
Chemicals, St. [.ouis, USA; Sphingomyelin was from Koch-Light, Eng-
land. All reagents were of highest grade available supplied by Merck,
Darmstadt, Germany and by Sigma Chemicals, St. lruis, USA.
P hosp holipids sd ptospAotqtid Veskla
Phosphatidykxhanolamine and phosphatidylserine (both 18:1-/
18: l";.) were prepared by cnzymatic synthesis (13). Phospholipid vesicles
were prepared by sonicatio in a buffer containing 50 mM TrisHCl and
175 mM NaCl pH 7.9 as described beforc (10). Tbe composition of the
vesicles was: 257o phcphatidylseine, ?3To phosphatidylethanolamine,
197o sphingomyelin, 28% phcphatidy'choline and cbolesterol in a 1: I
molar ratio with r€spec{ to the total phocpholipid concentration.
Proteirc
Bovine facton X2, IXa and thrombin were prepared as described
previously (6). Factor VIII:C was puritred from bovine blood using the
method of Vehar and Davie (fa), modifed as follows. After chromatogra-
phy on sulfatesepharoce we omitted the factor X-scpharose step because
factor VIII failed to bind to this @lumn. Thc final purification step for
factor VIU consisted of gelfihration on Sephacryl-S3fi). Factor VIII
eluted as a broad peak orresponding to the elution position of bovine
catalase (1v{' 82,m). Analpis of tbe colrrmn fractions by SD$polyacryl-
amide gelelectrophoresis followed by silver staining showed two prc-
dominant bands at 250,m and 74,0m. Factor VIII stock solutions were
dialyzed against a buffer contrining 10 mM morpholinoethane suffonic
acid, 175 mM NaCl, 10 mM CaCl2, 10% glycerol, adjusted to pH 6.5 with
I M Tris. Factor VIII was diluted in tlc same buffer containing 10 mg/ml
human albumin.
Activation of Facnr YIII
Factor VIII was activated by thrombil. Optimal onditior were
determined as described before by dircct mcasurcocnt of &c effect of
factor VIIIa on the rate of factor X uivation (6). In a tpicderyedncot
factor WII was activated for I min at 3T C and pH 7.9 Nt a tbo.nbin
concentration of 3.65 nM (130 ng/mt,0.!|6 NIH{ritYDl).
.Assav Systetn for Measurement of Factor X Activation
Factor IXa and phospholipid vesicles.were prewarmed at 37" C in
0.3 ml of a buffer containing 50 mM Tris-HCl. 175 mM NaCl, l0 mM
CaCll (pH 7.9). Factor X activation in the absence of facror VIIIa was
started by addition of 0.2 ml prewarmed factor X. After I min and 2 min
samples were taken and assaved for factor Xa using the chromogenic
substrate 52337 as described before (6). When factor VIIIa was present
the activation of factor X was started by the addition of 0. I ml factor X
and 0.1 ml act ivated factor  VI I I .  Samples were taken, l5 s and 90 s af ter
starting the reaction. Both in the presence and absence of factor VIIIc the
formation of factor Xa was linear with time for at least 3 min.
Quantification of Factor VIII
The concentration of factor VIII was determined by a one-stage
clotting assay using factor VIII deficient plasma and was expressed in
unitVml. assuming the presence of I unit/ml of factor VIII in plasma
pooled from 10 cows. The purified factor VIII preparation had a specific
activity of 1600-3000 unitvmg in a clotting assay, assuming that A'rh 
".: 10.0. It is uncertain which of the bands in the factor VIII:C preparation
as seen on SDS-gels are associated with the procoagulant activity.
Therefore the concentration of active factor VIII:C cannot be determined
from the absorbance at 280 nm. The results presented in this paper show
that the intrinsic factor X activator consists of a 1: I stoichiometrical
complex of phospholipid-bound factor IXa with phospholipid-bound
factor VIIIa. This enables the determination of the molar concentration
of factor VIIIa on the basis of its activity in factor X activation. The
method involves saturation of a limiting known amount of factor IXa with
factor VIIIa, followed try saturation of a limiting unknown amount of
factor VIIIa with factor IXa. When u (VIIIa) and u (IXa) are the rates of
factor X activation determined for a known concentration of factor IXa
saturated with factor VIIIa and for an unknown amount of factor VIIIa
saturated with factor IXa, respectively, the molar factor VIIIa concentra-
tion can be calculated from the equation:
u (IXa) u (VIIIa)
fwlal 
: 
fx"l
Table I Assembly of the intrinsic factor X activating complex in absence
and presence of factor VIIIa at varving phospholipid and factor X
concentrations
Components in Absence of
reaction mixture factor VIIIa
Presence of
factor VIIIa
Factor X Phospho-Kd+n
lipid factor IXa
(pM) (pM) (nM)
u (IXa) Kd"PP u (IXa)
factor IXa
(nM Xa/min) (nM) (nM Xa/min)
0.5
0.5
0.5
0.2
0.05
2.8
rc.4
23.2
14.3
6.1
10.0
1 6 . 1
5 . 1
3 .0
9 . 1
1 1 . 4
r2.3
7.2
r0 370
25 770
50 1110
50 830
50 480
The reaction conditions were as described in Fig. 1. The concentration
of factor VIIIa, when present, was 0.017 nM. u (lXa) is the rate of
factor X activation at infinitely high concentration of factor IXa. KdqP is
the factor IXa concentration required to obtain 0.5 u (IXa).
additional 200,000-fold rate enhancement. Kinetic analysis (6)
revealed that factor VIIIa increases the Vmax of factor X activa-
tion whereas the presence of a phospholipid surface decreases the
Km for factor X. These effects of accessory components on the
kinetic parameters of factor X activation do explain the above
mentioned rate enhancements. The drop of the Km in the
presence of phospholipids is explained in a model in which
phospholipids promote the formation of the enzyme-substrate
complex by binding both factor IXa and factor X. The factor X
and factor IXa concentrations in the presence of phospholipids
can be chosen such that only factor IXa molecules which are
incorporated in either factor lXa-phospholipid- or factor IXa-
factor Vllla-phospholipid oomplexes (factor IXa6o,n6) contribute
to the rate of factor X activation (V). In that case
V : c.[IXa]u"""a (I)
where c is a proportionality factor determined by the kinetic
parameters of factor X activation. The dissociation constant Kd
for dissociation of factor IXa from kinetically functional binding
sites is given by
Results
Derivation of Binding Parameters from Kinetic Measurements
In previous studies (6) we have demonstrated that the rate of
activation of factor X by factor IXa is increased in 3 orders of
magnitude by negatively charged phospholipids and that the
presence of the non-enzymatic protein cofactor vIIIa causes an
(IDK d = [IXal6- . ([sitesl.'r-[IXalu",,a)
IIXal6.,,,a
0 5 1 0 1 5 2 0 2 5 3 0
factor lXa (nM)
Fig. I. Effect of factor IXa on the rate of factor X activation in the abaence and presence of factor VIIIa. Factor IXa and phospholipid vesicles vere
prewarmed at 37. C in 0.3. ml of a buffer containing 50 mM Tris-HCl, 175 mM NaCl, 10 mM CaCt , pII7.9. Factor X activation was started by additioo
of 0.2 ml prewarmed factor X (panel A) or 0.1 ml of activated factor VIII plus 0.1 ml of factor X (panel B). After 60 s and 120 s (A) or 45 $ and 90 s( B ) samples were taken and assayed for factor Xa as described in Expcrimental Procedures. The final omposition of the reaction mixtures was: factor
IXa as indicated, 25 pM phospholipid, 0.5 pM factor X, 50 rnM Tris-HCl (pH 7.9), 175 mM NaCl, 6 -U C"Ctr, 0.5 mg/ml human albumin. The
composition of the reaction mixtures of the experiments shown in panet B were identical to panel A, except for the presere ia B of thromtfn-actirntcd
factot VIII in a frnal concentration of 0.012 otvt 1O.Ott unityml). The iffets depict double-reciprocal plos of the titration curves.
.s
E
6
x
c
1/lXa
,vt
Table 2 Factor lXa tirrations at ti)ur different factor Vllla concentra-
t ions
Factor
V I l l a
Kd'pp r r  ( lXa ) u ( lxa)/[VIIIa]
( nN{ ) (NM Xa/min) (nM Xalmin
per nM VIIIa)
in which [IXa]1... is the concentration factor IXa free in solution
and lsites]rotut is the total concentration of factor IXa binding sites
(phospholipid or factor Vllla-phospholipid). Rearrangement of
equation II  yields:
IIXa]6oun6
I
Isites],o,u1
Kd (rrr)
0.0  125
t).033
0.0375
0.  I
t6.7
t7. r i
I -1. tJ
16 .0
I 1 . 3
28.2
35.2
92.6
984
855
939
926
[IXa]6... . [sites],o,u;
Substitution of equation I in III results in:
l  l l
V  c I
Kd
* t . }
[sites],o,u' .lThe Kd'PP and u (IXa) values
recrprocal plots shown in Fig.2.
were calculated fronr the double
1/DG (nM)-l
Fig.2 Double reciprocal plots of the effect of factor IXa on the rate of
factor X activation at varying concentration of activated factor VIII.
Factor IXa titration curves were made at four different factor VIIIa
concentrations as described in the legend of Fig. l. The final composition
of the reaction mixtures (0.5 ml) was: 50 pM phospholipid, 0.5 pM
factor X, 3-50 nM factor lxa,50 mM Tris-HCl (pH 7.9), 175 mM NaCl,
6 mM CaClz, 0.5 mg/ml human albumin and (O-O), 0.0125 nM factor
VIIIa; (1-1), 0.033 nM factor VIIIa; (l-{), 0.0375 nM factor
VIIIa (O--{), 0.1 nM factor VIIIa.
Factor Vllla (nM)
Fig.3 Effect of varying amounts of activated factor VIII on the rate of
faclor X activation in the presence of a limiting amount of factor IXa.
Factor X activation was measured as described in the legend to Fig.18.
Factor VIII was activated at a constant conoentration of 70 UnitVml
whith 3.65 nM thrombin. The final composition of the reaction mixnrc
for factor X activation was: 50 mM Tris-HCl (pH 7.9), 175 mM NaCl,
6 mM CaCl3, 2.5 mg/ml ovalbunin, factor VIIIa as indicated in the Fig.,
0.017 nM factor IXa, 25 pM phospholipid and 0.5 pM factor X2.
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IIXa]6*. . [sites],o,";
(IV)
A plot of V-rvs. [IXa]61. is linear, with the intercept at the
ordinate being c-t[sites];',"1 and the intercept at the abcissa equal
to -Kd-I. The Kd is the concentration [IXa]6"" required to
occupy 50"/" of the sites,o,"1, which will result in half-maximal
factor X activation rates. When [IXa]6ouna ( [IXa]6"" (a condition
met in the experiments presented in this paper), the free
factor IXa concentration equals the total added concentration of
factor IXa, which allows the estimation of the binding parameters
of factor IXa for phospholipid from intercepts in plots of V-rvs
IIXa]-.1"1.
Assetnbly of the Intrinsic Factor X Activating Complex, Studied
by Varying the Factor IXa Concentration.
The relationship between the rate of factor X activation and
the concentration of factor IXa, in the presenie of phospholipids,
was examined to determine whether binding parameters for
factor IXa could be derived from kinetic experiments. In the two
experiments shown in Fig. 1, initial rates of factor X activation
were.determined as a function of the concentration factor IXa at
fixed concentrations of phospholipids vesicles (25 FM) and fac-
tor X (0.5 pM). In panel A no factor VIIIa was added and in
panel B thrombin activated factor VIII was Present at a concen-
tration of 0.012 nM (0.011 unityml). In both experiments the rate
of factor X activation reached a plateau value and could, there-
fore, be saturated with respect to factor IXa. However the
factor IXa conc€ntration required for saturation was considerably
lower in the presence of factor VIIIa (B) than in is absence (A).
Double-reciprocal plots of the data of Fig. 1 show a linear
relationship behpeen the plotted variables. Straight lines in
double-reciprocal plots are in accordance with equation IV. This
expression was derived for titration of single identical binding
sites with factor IXa, which upon occupation, contribute to the
rate of factor X activation. As is outlined in the appendix, the
formation of functional complexes containing factor IXa and
factor VIIIa in a stoichiometry different from 1:1 can be ruled
out. By applylng equation fV to the kinetic data, apparent Kd
values for the dissociation of faclor IXa from factor lXa-phos-
pholipid and factorlXa-factorVllla-phospholipid complexes
could be calculated. The Kde found in the absence of factor
VIIIa was 770 rM and in the presence of factor VIIIa 10 nM.
Additional titrations with factor IXa both in the absence and
pres€nc€ of factor VIIIa were carried out at varying phospholipid
and factor X concentrations. All double-reciprocal plots were
linear, and binding and kinetic data calctrlated from the plots are
summarized in Table 1. It is shown that all Kdry values for
factor IXa are 50-1fi) fold lowered by the prwence of factor
VIIIa, indicating that factor fXa has a higher affinity for
factorVllla-phospholipid complexes than for phospholipid
alone. The small effects of varying phospholipid and factor X
concentrations on KdEPp will be further considered in the discus-
sion.
In the absence of factor VlIIa, thc u (Dh) values (rates of
factor X activation obtained by extrapolation to infinitely hi8h
concentration of factor D(a) increased at increasing phcpbolipid
.g
E
6
x
5
^
,E
E
(d
x
c
concentrations. The proportional increase of u (IXa) with the
phospholipid concentration is consistent with an increased
number of binding sites for factor IXa available at the phos-
pholipid surface. In the presence of factor VIIIa, u (IXa) was
hardly affected by the phospholipid concentration. suggesting that
under.these conditions factor VIIIa rather than phospholipid
limits the total amount of facror lXa-factor Vllla-phospholipid
complexes which can be formed. Both in the absence and
presence of factor VIIla, decrease of the factor X concentration
resulted in a decrease of u (IXa), which is due to the fact that rates
of factor X activation were measured at a factor X concentration
around the Km. The Km for factor X at 50 pM phospholipid was
0. 15 pM in the absence of factor VIIIa and was 0.053 pM with
factor VIIIa (data not shown).
To test the suggestion that. at the phospholipid concentrations
give n in Table 1 and Fig. l, factor VIIIa is the limiting componenr
for the functional binding sites for factor IXa, titrations with
factor IXa were carried out at four different factor VIIIa concen-
trations. The double-reciprocal plots obtained are shown in Fig.2
and the binding and kinetic parameters derived from these plots
are summarized in Table 2. The u (IXa) increases proportionally
with the amount of factor VIIIa present. The Kd"PP is not
influenced by the factor VIIIa concentration indicating that the
affinity of factor IXa for functional binding sites is independent of
the amount of factor VIIIa present. These results and the
observation that in the presence of factor VIIIa variation of the
phospholipid concentration does not affect the u (IXa), strongly
suggest that in these experiments most of the factor VIIIa
molecules are bound to the phospholipid bilayers where they form
the catalytically functional binding sites for factor IXa.
Assembly of the Factor X Activating Complex at Increasing
Factor VII Ia Concentatioru
Having shown that the rate of factor Xa formation at limiting
factor VIIIa concentrations is saturable with respect to fac-
tor IXa, it was of interest to examine whether with limiting
amounts of factor IXa, the rate of factor Xa formation could also
be saturated with factor VIIIa. Varying amounts of activated
factor VIII were added to reaction mixtures containing fac-
tor IXa, phospholipid, Ca2* and factor X. The factor IXa con-
centration determined by active-site titration (15) was 0.017 nM.
As shown in Fig.3, the rate of factor X activation was also
saturable with factor VIIIa. The double-reciprocal plot is linear
and from the intercept at the abscissae a Kd"PP of 6.7 nM is
calculated for the binding of factor VIIIa to factor IXa in the
presence of phospholipid. This value is in the same range as the
Kd"pp values determined for factor IXa binding to phospholipids
in the presence of factor VIIIa. Under the same experimental
conditions (25 pM phospholipid and 0.5 pM factor X the Kd'pp
for factor IXa binding to phospholipid-bound factor VIIIa is
l0 nM (see Table 1).
Discussion
In this paper we present evidence for the hypothesis that
during intrinsic factor X activation, factor IXa and factor VIIIa
are complexed together at the phospholipid surface. Evidence for
factor lXa-factor VIIIa interaction is provided by the observation
that the rate of factor X activation is saturable with excess
factor IXa in the presence of limiting amounts of factor VIIIa and
vice versa. The amount of complex that is formed was propor-
tional with the amount of limiting component present. The
saturation curves were hyperbolic suggesting that single identical
sites were titrated in each case . Bv titration of a limited amount of
factor VIIIa with factor IXa in ih" pr"r"n"" of phospholipid a
Kdupp for factor IXa between 3-16 nM was found. Titration of a
limited amount of factor IXa with factor VIIIa in the presence of
phospholipid resulted in a Kd"pp of 6.7 nM for factor VIIIa.
We further carried out factor X activation experiments in the
absence of factor VIIIa. The Kdupp for factor IXa binding to
phospholipids obtained from kinetic experiments varied between
0.4-1.1 prM. These values are comparable to binding parameters
determined by Nelsestuen et al. (8) in direct binding studies. At a
suboptimal Ca:* concentration they observed a Kd of 2 pM for
dissociation of factor IX or RW-activated factor IX from phos-
pholipid vesicles.
Comparison of factor X activation experiments in the absence
and presence of factor VIIIa indicates that the apparent Kd for
factor IXa binding is lowered 50-100 fold in the presence of
factor VIIIa. We conclude that factor VIIIa functions as a high
affinity binding site for factor IXa at the phospholipid surface. It
is likely that the combination of factor IXa-phospholipid and
factor lXa-factor VIIIa interactions promote the incorporation of
factor IXa into the factor X activating complex. In that respect
factor VIIIa has a similar function as factor Va in prothrombin
activation. Nesheim et al. (11) and Lindhout et d. (12) reported
that factor Va promotes the binding of factor Xa to negatively
charged phospholipid surfaces.
The dependence of Kdry from the phospholipid and the
factor X concentration is not completely understood. The follow-
ing factors may contribute to the observed dependence: a) Up to
l5"h of added factor IXa is bound, which at the higher phos-
pholipid concentration results in somewhat higler Kd+c values b)
Factor X binds to phospholipids with a Kd of 50 nM (9) and may
compete with factor IXa for binding to the phospholipid surface.
To appreciate the interaction of factor VIIIa with factor IXa and
phospholipids it would be important to study factor VIIIa binding
using a direct binding assay. Presently, however, the instabilityof
activated factor VIII preparations does not allow such an ap-
proach.
In our previous experiments on the intrinsic factor X activator
we used factor VIII complex consisting of factor VIII:C and von
Willebrand factor (6). In the present work we used a factor
VIII:C preparation (14) that contains little or no von Willebrand
factor. Using factor VIII complex, a Vmax of 5fi) moles of
factor Xa min-l per mol of factor IXa was rcported, whereas in
this study the Vmax value is 9fi). This result suggests that the von
Willebrand factor does not strongly influence the Vmax of factor
Xa formation.
The physiological implications of the high-affinity binding sites
for factor IXa, formed by factor VIIIa at a lipid- or activated
platelet surface appear important. The concentration of factor
VIII in human plasma is 0.25 nM (unpublished observations).
The concentration of factor IX, which is at least 2OGfold higher,
is approximately 60 nM (16). During the coagulation process only
small amounts of factor IX are converted into factor IXa and the
concentrations of factors VIIIa and IXa will remain in the
nanomolar range. The 50-100 fold lowering of the Kd for
factor IXa binding (to the nM range) by fac'tor VIIIa therefore
allows more efficient factor lXa-factor VIIIa complex formation.
Previously we found that faclor VIIIa caused a 2il),Ofi) fold
enhancement of the Vmax of factor Xa formation (6). It now
appears that the overall enhanc€ment is explained by two major
effects of faclor VIIIa: a) greatly enhanced catalytic power of
factor lXa-Vllla-phospholipid, compared to factor Dk-phos-
pholipid; b) enhanced factor IXa affinity for the lipid surface in
the presence of factor VIIIa, which increases the amount of
phospholipid-bound factor IXa that participate,r in factor X acti-
vation.
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Appendix
A general equation can be derived, which describes the
relation between the reciprocal rate of factor X activation and the
reciprocai fiee ligand concentiation when the intrinsie factor X
activator consists of a complex of factor IXa and factor ViIIa with
a stoichiometry different from 1:1. When protein A at a fixed
concentration ([Al) is titrated with protein B and when ABn is the
enzymatically functional unit, the following binding equilibria are
involved:
A + B E A B
A B + B * A B ,
A B n _ l + B a A B n
tAl tBl^' = [a]
&: ##L
lAB,_, l lB lo" = 
LABJ
Since [A,] = [AB"] + [AB"-r] +........+ [AB] + [A] and the
reaction rate V = c.[ABnl (c is a proportionality factor deter-
mined by the kinetic parameters of the reaction catalyzed by
AB"), the following relation between 1A/ and 1/[B] is obtained:
'^,:.,hiII: #. $: +r".fr+r)
From this equation it is obvious that only if n : I
stoichiometry) 1/V will be linearly proportional with 1/[B].
